Navigation Links
Doing the pharmaceutical tango

The tango is an elaborate, elegant, and emotional Argentine dance that embodies a combination of rapid and slow movements. The word tango has worked its way into our vocabulary: "It takes two to tango" means that one person doesn't make a major mistake or screw-up, it usually requires the work of two.

The tango often seems like a battle of two people trying......

Full article >>> percent of Merck's 2005 worldwide sales - totaling $22 billion - were from in-licensed products.

This number is actually even higher as it doesn't reflect the co-marketing deal with Schering-Plough for the cholesterol drug Zetia, which Merck doesn't reflect as sales, but does have an important income impact. ......

Full article >>> to the WSJ article, the combination of German Merck/Serono will be known as Merck-Serono Biopharmaceuticals for the prescription drug part of the business, with its headquarters in Geneva and Boston (both Serono operations). It also will have combined annual pharma sales of about $4.6 billion, an annual R&D budget of about $1.3 billion, and a worldwide sales force of 7,000.

More than th......

Full article >>> ompanies into the top tier ranks of pharma companies. The 10th-ranked big pharma company, Wyeth, had 2005 sales of almost $19 billion. In fact, Merck KGaA, Nycomed, and UCB probably will not even crack the list of the top 20 big pharmas. Still, these acquisitions probably were what they could afford, and at least temporarily will allow them to avoid be......

Full article >>> br>
Blue color= 2006 transactions

I think there are still some potential transactions that will take place before the end of the year. Two companies that have been in the target list are Bristol-Myers Squibb and Schering-Plough.

Bristol-Myers Squibb currently has a market valuation of about $49.3 billion, while Schering-Plough's is $31.7 bill......

Full article >>> ished, with a price of about $44/share in 2002 compared to about $28/share today, or a drop of 36 percent.

This drop has rankled Pfizer shareholders as McKinnell is walking off with a potential $83 billion lump sum payment, according to BioPharm International. Additionally, McKinnell has departed at a time when several Pfizer blockbusters......

Full article >>> technology Industry Organization. He can be reached at rosenmichaels@aol.com.

The opinions expressed herein or statements made in the above column are solely those of the author and do not necessarily reflect the views of The Wisconsin Technology Network, LLC. (WTN). WTN, LLC, accepts no legal liability or responsibility for any claims made ......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 09/26/06


Related biology technology :

1. Life Science: From company creation to growth: Doing business in Wisconsin
2. Doing it Right: Business IT Fusion for the Future
3. Want to squeeze U.S. pharmaceutical companies? Be careful what you ask for
4. Online retailing "tango" is adding some steps
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... , Feb. 23, 2017  In Atlanta, it seems everyone ... and culture intertwine to create an expressive and dynamic community ... this energy and contribute to it. With ... Hair Fairies seeks to carry on that tradition with ... Atlanta salon is the newest of 13 ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... de novo clearance to begin marketing the SPEAC® System, the Brain Sentinel® Seizure ... at home or in healthcare facilities during periods of rest. A lightweight, non-invasive ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... (such as insulin, cortisol, CRP, adiponectin, uric acid, and/or other biomarkers or SNPs ... Insulin Assay from Salimetrics’ SalivaLab , the relationship between insulin and other ...
(Date:2/23/2017)... DIEGO , Feb. 23, 2017 ... research tools, announced the acquisition of GenWay Biotech ... a comprehensive service and product offering for both ... acquisition will facilitate growth and enhance capabilities for ... antibodies, and ELISA assays will nicely complement ASB,s ...
Breaking Biology Technology:
(Date:2/3/2017)... 2017  Texas Biomedical Research Institute announced that its Board ... as the Institute,s new President and CEO. Dr. Schlesinger ... 2017. He is currently the Chair of the Department of ... Microbial Interface Biology at Ohio State University. "We ... and CEO of Texas Biomed," said Dr. James O. ...
(Date:2/2/2017)... Feb. 2, 2017   TapImmune, Inc. ... company specializing in the development of innovative peptide ... of cancer and metastatic disease, announced today it ... manufacturing of a second clinical lot of TPIV ... receptor alpha. The manufactured vaccine product will be ...
(Date:2/2/2017)... TOKYO , Feb. 1, 2017  Central ... innovative and meaningful advances worldwide, The Japan Prize ... Japan Prize, who have pushed the envelope in ... Information and Communication. Three scientists are being recognized ... outstanding achievements that not only contribute to the ...
Breaking Biology News(10 mins):